ANTONIO
OSUNA ORTEGA
COLABORADOR EXTRAORDINARIO
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (9)
2023
-
Post-transplant diabetes mellitus and renal cell cancer after renal transplantation
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 6, pp. 1552-1559
2022
-
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study
Clinical transplantation, Vol. 36, Núm. 3, pp. e14550
2019
-
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study
Transplantation, Vol. 103, Núm. 9, pp. 1953-1963
2009
-
A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32
-
Hyperinsulinemia and hyperfiltration in renal transplantation
Transplantation, Vol. 87, Núm. 2, pp. 274-279
-
Poly[ADP-ribose] polymerase-1 expression is related to cold ischemia, acute tubular necrosis, and delayed renal function in kidney transplantation
PLoS ONE, Vol. 4, Núm. 9
2008
-
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: A prospective and multicenter study
Transplantation, Vol. 85, Núm. 8, pp. 1133-1138
-
Unmasking glucose metabolism alterations in stable renal transplant recipients: A multicenter study
Clinical Journal of the American Society of Nephrology, Vol. 3, Núm. 3, pp. 808-813
2006
-
Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain
Clinical Transplantation, Vol. 20, Núm. 5, pp. 650-658